Each retinoid molecule in Nourella® cream is surrounded by nano-encapsulation technology

Retilex-A®: The next-generation retinoid

The proprietary technology RetileX-A® creates an ‘envelope’ around each retinoid molecule in Nourella® cream, protecting molecules from light and oxidation and carrying them past the epidermis directly to the skin’s keratinocytes – where molecules are then released and can exert their full efficacy.

RetileX-A® was developed by Pharma Medico in Scandinavia as a next-generation retinoid and is backed by more than 30 years of research.

Nourella® Cream with Retilex-A® improves the structure and appearance of aged skin by:

• Normalising the thickness and texture of the epidermis
• Preventing the degradation of collagen and elastin
• Stimulating the synthesis of collagen and elastin
• Promoting angiogenesis and dermal blood perfusion
• Providing antioxidant and anti-inflammatory activities
• Depigmenting and inhibiting melanin synthesis

Development of Retilex-A® has focused on:

• Improving the overall absorbed dosage of retinyl palmitate by molecular stabilisation and reducing degradation
• Optimising transdermal delivery and diffusion of the active compound (300x increase compared to conventional retinoids)
• Extending the drug release and time available by its unique buffering effect
• Preventing drug–drug and drug–excipient interactions by providing physical and chemical protection
• Minimising adverse effects by restricting the contact time between the free retinoid and the skin surface
• Enhancing the stability and shelf life of Nourella® cream